Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist currently under clinical investigation and not licensed by the MHRA or EMA for use in the UK
Reviews Love it I've almost finished my first bottle
Maintaining adequate hydration and using moisturiser regularly can help support skin health
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are gaining increasing attention as first-line agents for the treatment of diabetes and obesity, and with their potential to improve the muscle mass and function, they provide new ideas for the treatment of sarcopenia
Theyre putting the right systems of support in place early and recognizing where GLP1 care is headed, not just where it is today
They are also considered allies in staving off cataracts, macular degeneration, and other serious eye conditions